Genmab A-S
Price & Volume
Stats
See more52W Range | $17.23-$30.41 |
Market Cap | $12.8B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $21.5B |
Revenue Growth (YoY) | 35.3% |
Gross Profit (12 Mos) | $20.5B |
Diluted EPS | $1.84 |
News
See moreYahoo Finance • 9 days ago
Transactions in Connection with Share Buy-back Program
Yahoo Finance • 16 days ago
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
Yahoo Finance • 20 days ago
Genmab A/S Share Capital Reduction
Yahoo Finance • 24 days ago
Transactions In Connection with Share Buy-back Program
About
CEO | Dr. Jan G.J. van de Winkel Ph.D. |
CFO | Mr. Anthony Pagano CPA |
Address | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,682 |
